GenomeWeb

Epic Sciences Receives CAP Accreditation

Jan 11, 2016

NEW YORK (GenomeWeb) – Epic Sciences announced today that its San Diego laboratory has received accreditation from the College of American Pathologists.

Epic markets a platform it calls "no cell left behind," which isolates circulating tumor cells in an unbiased manner, allowing downstream analyses of single CTCs using genomic, proteomic, and morphologic approaches.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

Epic Sciences Receives CAP Accreditation

To read the full story....

Breaking News

BGI, Aid Genomics Partner to Build COVID-19 Testing Lab in Gaza

Coriell Institute Awarded $9.2M to Continue Operating NIGMS Biobank

Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery

Top Five Articles on GenomeWeb Last Week: FDA, Qiagen, Color, and More

Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

The Scan

Another Paper Gone

Computational Biologist James Taylor Dies

Ever Infected

PLOS Papers on Hepatocellular Carcinoma Immune Cells, Regulatory Prostate Cancer Risk SNPs, More

What's Popular?

Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

Co-Diagnostics Gets FDA Emergency Use Authorization for Coronavirus Test

LexaGene Shifts Gears to Prepare Viral RT-qPCR Panel for FDA Emergency Submission

Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery

BGI, Aid Genomics Partner to Build COVID-19 Testing Lab in Gaza

Sponsorships